publication date: Sep. 5, 2014

html Briefs.html

George Weiner to be President of AACI; Stanton Gerson Chosen as President-elect

GEORGE WEINER will begin a two-year term as president of the Association of American Cancer Institutes following its annual meeting in Chicago, Oct. 26-28.

Weiner is director of the Holden Comprehensive Cancer Center at the University of Iowa. He is also the C.E. Block Chair of Cancer Research, professor of internal medicine, and a faculty member in the Interdisciplinary Graduate Program in Immunology at the University of Iowa.

He will succeed current AACI President Michelle Le Beau, the Arthur and Marian Edelstein Professor of Medicine and director of the University of Chicago Comprehensive Cancer Center.

During her presidency, Le Beau launched the AACI’s Molecular Diagnostics Initiative, which examines challenges impeding the implementation of comprehensive molecular diagnostics within cancer centers.

Weiner said that he would focus his AACI presidency on “the academic difference,” the role academic cancer centers play in cancer patient care and research.

AACI also announced the election of Stanton Gerson as vice-president and president-elect.

Gerson is the Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology, director of the Case Comprehensive Cancer Center, founding director of the National Center for Regenerative Medicine, and a distinguished university professor at Case Western Reserve University.

He is also director of University Hospitals Seidman Cancer Center and a member of the NCI Board of Scientific Advisors.

In a statement to AACI members, Gerson said he will prioritize three critical aspects of the nation’s cancer centers program by: 1) encouraging the centers to work … Continue reading 40-33 In Brief

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.